Prindiville T P, Sheikh R A, Cohen S H, Tang Y J, Cantrell M C, Silva J
University of California, Davis Medical Center, Sacramento, CA, USA.
Emerg Infect Dis. 2000 Mar-Apr;6(2):171-4. doi: 10.3201/eid0602.000210.
We identified enterotoxigenic Bacteroides fragilis in stool specimens of patients with inflammatory bowel disease and other gastrointestinal disorders. The organism was detected in 11 (13.2%) of 83 patients with inflammatory bowel disease. Of 57 patients with active disease, 19.3% were toxin positive; none of those with inactive disease had specimens positive for enterotoxigenic Bacteroides fragilis gene sequences.
我们在炎症性肠病和其他胃肠道疾病患者的粪便标本中鉴定出产肠毒素脆弱拟杆菌。在83例炎症性肠病患者中，有11例（13.2%）检测到该菌。在57例活动期疾病患者中，19.3%毒素呈阳性；非活动期疾病患者中，没有一份标本的产肠毒素脆弱拟杆菌基因序列呈阳性。
